Systems and methods for treating eyelid inflammation

An eyelid treatment system comprising:

• a substrate including an inner concave surface and an outer convex surface opposite the inner concave surface, the substrate configured to be placed external to an eye of a subject, the outer concave surface being configured to at least partially block ambient light from being transmitted through the outer convex surface in a direction towards the inner concave surface;
• a light source configured to deliver light to an outer surface of an eyelid of the subject when the substrate is placed over the eyelid of the subject;
• and
• wherein the light from the light source is configured to improve eyelid inflammation.

An eyelid treatment system comprising:

• a first substrate including a first inner concave surface and a first outer convex surface opposite the first inner concave surface, the first substrate configured to be placed on an eye of a subject, the first inner concave surface being configured to at least partially block light from being transmitted through the inner concave surface away from the outer convex surface;
• a second substrate including a second inner concave surface and a second outer convex surface opposite the second inner concave surface, the second substrate configured to be placed external to the eye of the subject, the second outer convex surface being configured to at least partially block ambient light from being transmitted through the second outer convex surface in a direction towards the second inner concave surface;
• one or more light sources configured to emit light to at least one of an inner surface or an outer surface of the eyelid of the subject when the first substrate is placed on the eye of the subject and when the second substrate is placed over the eyelid of the subject;
• and
• wherein the light from the one or more light sources is configured to reduce eyelid inflammation.

A method of treating eyelid inflammation, the method comprising:

• placing a substrate on an eye of a subject or over an eyelid of the subject;
• causing one or more light sources coupled to the substrate or optically coupled to the substrate to emit first light towards the eyelid or towards the substrate;
• and
• reducing eyelid inflammation from the first light by:
• the first light emitted from the one or more light sources and directed towards the eyelid causing a therapeutic effect in the eyelid tissue that decreases eyelid inflammation of the eyelid;
• or
• the first light emitted from the one or more light sources and directed towards the substrate causes the substrate to emit a second light different from the first light towards the eyelid, the second light causing a therapeutic effect in the eyelid tissue that decreases eyelid inflammation of the eyelid.